RecruitingNCT04134923

Imaging Biomarkers in Preclinical and Symptomatic AD

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tammie L. S. Benzinger, MD, PhD
Principal Investigator
Tammie Benzinger, MD, PhD
Washington University School of Medicine
Intervention
[11C] Pittsburgh Compound-B (PIB)(drug)
Enrollment
375 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2029

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04134923 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials